BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2023 11:20:34 AM | Browse: 260 | Download: 747
 |
Received |
|
2022-12-26 05:31 |
 |
Peer-Review Started |
|
2022-12-26 05:33 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-02-02 02:12 |
 |
Revised |
|
2023-02-20 05:56 |
 |
Second Decision |
|
2023-03-15 02:58 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-03-15 09:10 |
 |
Articles in Press |
|
2023-03-15 09:10 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-03-16 01:47 |
 |
Publish the Manuscript Online |
|
2023-03-22 11:20 |
ISSN |
1948-5182 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Emerging role of engineered exosomes in nonalcoholic fatty liver disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jian Ding, Chen Xu, Ming Xu, Xiao-Yue He, Wei-Na Li and Fei He |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
81970535 |
|
Corresponding Author |
Fei He, PhD, Research Associate, Department of Hepatobiliary Surgery, Xi-Jing Hospital, No. 127 Changle West Road , Xi'an 710032, Shaanxi Province, China. hefei_hefei@163.com |
Key Words |
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Exosome; Engineered exosome; Targeted therapy |
Core Tip |
Nonalcoholic fatty liver disease (NAFLD) is the fastest growing chronic disease in the world. As the disease progresses, NAFLD can lead to liver fibrosis, cirrhosis and even liver cancer. However, a well-established treatment for NAFLD has yet to be identified. Exosomes are small extracellular vesicles secreted by cells. Owing to their high delivery efficiency and biocompatibility, exosomes are expected to become a new means of drug delivery and precise treatment for a variety of diseases, including NAFLD. |
Publish Date |
2023-03-22 11:20 |
Citation |
Ding J, Xu C, Xu M, He XY, Li WN, He F. Emerging role of engineered exosomes in nonalcoholic fatty liver disease. World J Hepatol 2023; 15(3): 386-392 |
URL |
https://www.wjgnet.com/1948-5182/full/v15/i3/386.htm |
DOI |
https://dx.doi.org/10.4254/wjh.v15.i3.386 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345